Breaking News Instant updates and real-time market news.

TXMD

TherapeuticsMD

$5.67

0.1 (1.80%)

07:23
08/11/17
08/11
07:23
08/11/17
07:23

TherapeuticsMD launch may be only delayed six months, says Stifel

After the FDA said it would review additional data from TherapeuticsMD on vaginal estrogen use and set a November 3 meeting date with the company, Stifel analyst Annabel Samimy thinks the FDA's moves indicate "the data are meaningful enough to satisfy the safety question in the CRL." She thinks that the company's program may be no more than six months delayed from the original plan, and she keeps a $20 price target and a Buy rating on the shares.

TXMD TherapeuticsMD
$5.67

0.1 (1.80%)

08/11/17
DBAB
08/11/17
NO CHANGE
Target $10
DBAB
Buy
TherapeuticsMD announcement a 'small positive,' says Deutsche Bank
Deutsche Bank analyst Esther Rajavelu views TherapeuticsMD's announcement that the FDA will review in detail, as part of the data package for TX-004, a large NIH-sponsored observational study on long-term, real world use of vaginal estrogens as a "small positive." While the analyst remains cautious on the timing and outcome of the review, she sees the news as an "incremental step in the right direction." Rajavelu continues to model for a TX-004 launch in 2019. The analyst keeps a Buy rating on TherapeuticsMD with a $10 price target.
08/04/17
OPCO
08/04/17
NO CHANGE
Target $10
OPCO
Outperform
TherapeuticsMD talks with FDA increasingly collaborative, says Oppenheimer
After TherapeuticsMD provided an update on the regulatory process for both TX-004HR and TX-001HR, Oppenheimer analyst Jay Olson says he believes the narrative between the company and the FDA has become "more collaborative." This suggests next week's potential update on TX-004HR could be favorable, Olson tells investors in a research note. The analyst keeps an Outperform rating on TherapeuticsMD with a $10 price target.
07/21/17
DBAB
07/21/17
INITIATION
Target $10
DBAB
Buy
TherapeuticsMD initiated with a Buy at Deutsche Bank
Deutsche Bank analyst Esther Rajavelu started TherapeuticsMD with a Buy rating and $10 price target. Current trading levels do not fully reflect the TX-001 market opportunity and provide an attractive entry point for investors, the analyst contends. Rajavelu sees upside from current trading levels regardless of the regulatory outcome for TX-004.
07/17/17
STFL
07/17/17
NO CHANGE
Target $20
STFL
Buy
Stifel sees high likelihood FDA lets TherapeuticsMD do post-marketing study
Stifel analyst Annabel Samimy said a lack of clarity is pressuring TherapeuticsMD shares after the company provided a regulatory update on the status of its New Drug Application for TX-004HR, but he thinks there is a high likelihood that the FDA will allow the company to proceed with a post-marketing safety study. Samimy, who still expects a resubmission within weeks and FDA action within two months, keeps a Buy rating and $20 price target on TherapeuticsMD.

TODAY'S FREE FLY STORIES

FL

Foot Locker

$39.80

7.95 (24.96%)

12:32
11/17/17
11/17
12:32
11/17/17
12:32
Upgrade
Foot Locker rating change  »

Deutsche sees sustained…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Nov

XRT

S&P Retail Index SPDR

$41.59

0.98 (2.41%)

12:30
11/17/17
11/17
12:30
11/17/17
12:30
Options
Defensive short-term play in SPDR Retail ETF »

Defensive short-term play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:30
11/17/17
11/17
12:30
11/17/17
12:30
General news
Breaking General news story  »

San Francisco Federal…

FTI

TechnipFMC

$26.72

0.175 (0.66%)

12:25
11/17/17
11/17
12:25
11/17/17
12:25
Options
FMC Technologies call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

$NSD

NASDAQ Market Internals

12:17
11/17/17
11/17
12:17
11/17/17
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMD

AMD

$11.25

0.18 (1.63%)

12:16
11/17/17
11/17
12:16
11/17/17
12:16
Options
AMD calls outpace puts 4:1 as shares advance »

AMD calls outpace puts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

TSLA

Tesla

$312.50

1.2 (0.39%)

, AMZN

Amazon.com

$1,137.29

10.6 (0.94%)

12:16
11/17/17
11/17
12:16
11/17/17
12:16
Hot Stocks
Tesla, Amazon look to shake up trucking industry with new vehicle, app »

Shares of third-party…

TSLA

Tesla

$312.50

1.2 (0.39%)

AMZN

Amazon.com

$1,137.29

10.6 (0.94%)

CHRW

C.H. Robinson

$80.40

0.45 (0.56%)

LSTR

Landstar System

$96.80

1.75 (1.84%)

XPO

XPO Logistics

$74.29

0.1035 (0.14%)

JBHT

J.B. Hunt

$102.98

1.44 (1.42%)

WMT

Wal-Mart

$96.94

-2.68 (-2.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Nov

  • 20

    Nov

  • 21

    Nov

  • 21

    Nov

  • 28

    Nov

  • 07

    Dec

  • 11

    Dec

  • 09

    Jan

  • 16

    Jan

  • 20

    Feb

  • 18

    Mar

$NYE

NYSE Market Internals

12:16
11/17/17
11/17
12:16
11/17/17
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDXG

MiMedx

$11.36

-0.58 (-4.86%)

12:12
11/17/17
11/17
12:12
11/17/17
12:12
Recommendations
MiMedx analyst commentary  »

MiMedx growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 30

    Nov

  • 01

    Dec

XOP

SPDR Oil Exploration and Production Fund

$34.83

0.525 (1.53%)

12:00
11/17/17
11/17
12:00
11/17/17
12:00
Options
Defensive short-term option play in SPDR Oil Exploration and Production ETF »

Defensive short-term…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNK

Teekay Tankers

$1.41

0.01 (0.71%)

11:55
11/17/17
11/17
11:55
11/17/17
11:55
Conference/Events
Teekay Tankers to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Nov

TWX

Time Warner

$88.53

0.52 (0.59%)

, VIA

Viacom

$30.10

-0.65 (-2.11%)

11:50
11/17/17
11/17
11:50
11/17/17
11:50
Hot Stocks
Box Office Battle: 'Justice League' to vanquish 'Thor' in debut »

The major release opening…

TWX

Time Warner

$88.53

0.52 (0.59%)

VIA

Viacom

$30.10

-0.65 (-2.11%)

VIAB

Viacom

$23.69

-0.92 (-3.74%)

LGF.A

Lionsgate

$32.32

1.28 (4.12%)

LGF.B

Lionsgate

$30.70

1.17 (3.96%)

DIS

Disney

$103.61

0.01 (0.01%)

FOX

21st Century Fox

$28.60

0.65 (2.33%)

FOXA

21st Century Fox

$29.32

0.59 (2.05%)

CMCSA

Comcast

$37.07

-0.11 (-0.30%)

CMCSK

Comcast

SNE

Sony

$46.20

0.1 (0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANF

Abercrombie & Fitch

$15.49

2.9398 (23.42%)

11:50
11/17/17
11/17
11:50
11/17/17
11:50
Recommendations
Abercrombie & Fitch analyst commentary  »

Abercrombie & Fitch…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Nov

HFWA

Heritage Financial

$30.60

0.3 (0.99%)

11:48
11/17/17
11/17
11:48
11/17/17
11:48
Hot Stocks
Heritage Financial, Puget Sound Bancorp deal receives regulatory approvals »

Heritage Financial, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EEM

MSCI Emerging Markets Index

$46.81

0.215 (0.46%)

11:40
11/17/17
11/17
11:40
11/17/17
11:40
Options
108K iShares Emerging Markets Fund Dec 44.5 puts bought for 22c »

108K iShares Emerging…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:35
11/17/17
11/17
11:35
11/17/17
11:35
General news
Euro$ interest rate futures recovered from lows »

Euro$ interest rate…

ANF

Abercrombie & Fitch

$16.00

3.45 (27.49%)

11:31
11/17/17
11/17
11:31
11/17/17
11:31
Downgrade
Abercrombie & Fitch rating change  »

Abercrombie & Fitch…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Nov

M

Macy's

$20.63

0.38 (1.88%)

11:30
11/17/17
11/17
11:30
11/17/17
11:30
Options
Calendar risk reversal in Macys may roll call gains into put protection »

Calendar risk reversal in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

ANF

Abercrombie & Fitch

$15.94

3.39 (27.01%)

11:28
11/17/17
11/17
11:28
11/17/17
11:28
Downgrade
Abercrombie & Fitch rating change  »

Abercrombie & Fitch…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Nov

AAPL

Apple

$171.10

2.02 (1.19%)

11:24
11/17/17
11/17
11:24
11/17/17
11:24
Periodicals
Apple delays release of HomePod to early 2018, TechCrunch reports »

Apple is delaying the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

V

Visa

$110.15

-0.87 (-0.78%)

, MA

MasterCard

$148.53

-1.7995 (-1.20%)

11:23
11/17/17
11/17
11:23
11/17/17
11:23
Recommendations
Visa, MasterCard analyst commentary  »

Visa highlights possible…

V

Visa

$110.15

-0.87 (-0.78%)

MA

MasterCard

$148.53

-1.7995 (-1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 29

    Nov

GLD

SPDR Gold Trust

$122.32

0.92 (0.76%)

11:20
11/17/17
11/17
11:20
11/17/17
11:20
Options
Far downside put buyers in SPDR Gold ETF as the metal trades higher »

Far downside put buyers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

11:17
11/17/17
11/17
11:17
11/17/17
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

11:16
11/17/17
11/17
11:16
11/17/17
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$312.50

1.2 (0.39%)

, WMT

Wal-Mart

$97.67

-1.952 (-1.96%)

11:05
11/17/17
11/17
11:05
11/17/17
11:05
Periodicals
Wal-Mart to test new Tesla electric trucks, CNBC reports »

Following Tesla's…

TSLA

Tesla

$312.50

1.2 (0.39%)

WMT

Wal-Mart

$97.67

-1.952 (-1.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

  • 21

    Nov

  • 16

    Jan

  • 20

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.